/Investor DB

Fund+ — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Cardior Pharmaceuticals GmbHcardior.deAug 2021

Clinical-stage biopharmaceutical company developing RNA therapeutics for cardiac disease.

Co-investorsBioMedPartnersHadean VenturesInkefEQT Life SciencesSunstone Capital

Novadip Biosciencesnovadip.cominOct 2021

Novadip develops regenerative medicine treatments using its 3M3 tissue regeneration platform to address conditions requiring bone and tissue repair, including spinal fusion, cancer recovery, and complex fractures.

BiotechDeep TechHealthtechMedical DevicesLouvain, BE

Dr. Denis Dufrane(Founder & Professor)in

BoardEric Paul Pâques(Chairman)

Co-investorsNew Science VenturesÉpimèdeVIVES PartnersWallonie EntreprendreSambrinvest

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.